Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

G3295-4

Sigma-Aldrich

ProtaSea® Fucoidan

brown seaweed extract

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Código UNSPSC:
12352201
NACRES:
NA.25

Nivel de calidad

100

Formulario

powder

pH

5.5-8.5 (20 °C, 1% in water)

viscosidad

5-10 mPa.s

Aplicación

NovaMatrix ProtaSea fucoidan is a brown seaweed extract from Laminaria Hyperborea. The product is manufactured in Norway from fresh seaweed sources, using natural extraction techniques. This allows ProtaSea fucoidans to be as close as possible to their natural state. Novamatrix ProtaSea fucoidan is 80% fucose. ProtaSea fucoidans can be used in personal care and nutraceutical products. ProtaSea fucoidans can potentially be used in drug therapy research, joint health, immune health, anti-inflammatory therapies, medical device coating, etc.

Información legal

Product of Dupont Nutrition USA, Inc.
PROTASEA is a registered trademark of DuPont Nutrition USA, Inc.

Cláusula de descargo de responsabilidad

NOT FOR USE IN HUMANS

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico